Takeda Pharmaceutical Operating Income 2012-2025 | TAK

Takeda Pharmaceutical annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Takeda Pharmaceutical operating income for the quarter ending December 31, 2025 was $0M, a 100% decline year-over-year.
  • Takeda Pharmaceutical operating income for the twelve months ending December 31, 2025 was $2.338B, a 58.28% increase year-over-year.
  • Takeda Pharmaceutical annual operating income for 2025 was $2.261B, a 53.07% increase from 2024.
  • Takeda Pharmaceutical annual operating income for 2024 was $1.477B, a 59.31% decline from 2023.
  • Takeda Pharmaceutical annual operating income for 2023 was $3.63B, a 11.5% decline from 2022.
Takeda Pharmaceutical Annual Operating Income
(Millions of US $)
2025 $2,261
2024 $1,477
2023 $3,630
2022 $4,102
2021 $23,480
2020 $924
2019 $1,845
2018 $2,176
2017 $1,450
2016 $1,086
2015 $-1,176
2014 $1,393
2013 $1,482
2012 $3,366
2011 $4,423
Takeda Pharmaceutical Quarterly Operating Income
(Millions of US $)
2025-12-31
2025-09-30
2025-06-30 $1,273
2024-06-30 $1,065
2024-03-31 $-126
2023-12-31 $713
2023-09-30 $-340
2023-06-30 $1,231
2023-03-31 $675
2022-12-31 $1,044
2022-09-30 $752
2022-06-30 $1,159
2022-03-31 $-72
2021-12-31 $1,025
2021-09-30 $887
2021-06-30 $2,262
2021-03-31 $20,096
2020-12-31 $1,374
2020-09-30 $454
2020-06-30 $1,556
2020-03-31 $-34
2019-12-31 $492
2019-09-30 $376
2019-06-30 $90
2018-12-31 $1,001
2018-06-30 $910
2017-06-30 $1,755
2016-06-30 $1,422
2015-06-30 $406
2015-03-31 $3,673
2014-12-31 $-10,919
2014-09-30 $4,076
2014-06-30 $612
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $509
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $892
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
Sector Industry Market Cap Revenue
Medical MED-DRUGS $56.926B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $92.346B 32.25
Zoetis (ZTS) US $56.153B 20.10
BeOne Medicines - (ONC) CH $38.812B 205.77
Sandoz Group AG (SDZNY) CH $35.065B 0.00
Daiichi Sankyo, - (DSNKY) JP $34.401B 0.00
United Therapeutics (UTHR) US $20.898B 18.39
Merck (MKKGY) DE $18.714B 11.54
Shionogi (SGIOY) JP $18.571B 14.36
Neurocrine Biosciences (NBIX) US $14.078B 33.78
Ionis Pharmaceuticals (IONS) US $14.011B 0.00
IPSEN (IPSEY) FR $13.491B 0.00
Summit Therapeutics (SMMT) US $11.560B 0.00
Orion OYJ (ORINY) FI $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) US $10.847B 0.00
Eisai (ESAIY) $8.574B 0.00
Ono Pharmaceutical (OPHLF) JP $7.149B 17.10
Stevanato Group S.p.A (STVN) IT $4.694B 26.27
Crinetics Pharmaceuticals (CRNX) US $4.626B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $4.591B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $4.565B 21.67
Indivior Pharmaceuticals (INDV) US $4.296B 17.53
Corcept Therapeutics (CORT) US $4.295B 46.40
NewAmsterdam Pharma (NAMS) NL $3.889B 0.00
Centessa Pharmaceuticals (CNTA) GB $3.158B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.004B 9.58
Hypermarcas (HYPMY) BR $2.755B 18.91
Dyne Therapeutics (DYN) US $2.399B 0.00
Soleno Therapeutics (SLNO) US $2.231B 0.00
Guardian Pharmacy Services (GRDN) US $2.145B 41.32
Avadel Pharmaceuticals (AVDL) IE $2.118B 0.00
Ocular Therapeutix (OCUL) US $1.994B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.904B 22.56
Ardelyx (ARDX) US $1.779B 0.00
Harrow (HROW) US $1.753B 107.54
Enliven Therapeutics (ELVN) US $1.746B 0.00
Definium Therapeutics (DFTX) US $1.665B 0.00
Oruka Therapeutics (ORKA) US $1.600B 0.00
Relay Therapeutics (RLAY) US $1.546B 0.00
Amylyx Pharmaceuticals (AMLX) US $1.535B 0.00
Collegium Pharmaceutical (COLL) US $1.505B 7.45
BioCryst Pharmaceuticals (BCRX) US $1.345B 79.75
Evotec AG (EVO) DE $1.254B 0.00
Xeris Biopharma Holdings (XERS) US $1.163B 0.00
Savara (SVRA) US $1.078B 0.00
Theravance Biopharma (TBPH) US $1.038B 43.57
Cronos Group (CRON) CA $1.004B 0.00
ARS Pharmaceuticals (SPRY) US $0.991B 0.00
Aktis Oncology (AKTS) US $0.961B 0.00
Xencor (XNCR) US $0.829B 0.00
Esperion Therapeutics (ESPR) US $0.813B 0.00
KalVista Pharmaceuticals (KALV) US $0.753B 0.00
Nektar Therapeutics (NKTR) US $0.749B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.742B 17.54
Bioventus (BVS) US $0.704B 14.42
Rigel Pharmaceuticals (RIGL) US $0.620B 5.53
ProKidney (PROK) US $0.563B 0.00
Altimmune (ALT) US $0.550B 0.00
Lexeo Therapeutics (LXEO) US $0.523B 0.00
4D Molecular Therapeutics (FDMT) US $0.514B 0.00
Aquestive Therapeutics (AQST) US $0.501B 0.00
Zevra Therapeutics (ZVRA) US $0.484B 0.00
Lyell Immunopharma (LYEL) US $0.482B 0.00
Elite Pharmaceuticals (ELTP) US $0.481B 0.00
Siga Technologies (SIGA) US $0.480B 6.57
Organogenesis (ORGO) US $0.478B 0.00
Nature's Sunshine Products (NATR) US $0.461B 27.43
USANA Health Sciences (USNA) US $0.390B 10.89
Aclaris Therapeutics (ACRS) US $0.387B 0.00
Akebia Therapeutics (AKBA) US $0.369B 0.00
Protara Therapeutics (TARA) US $0.343B 0.00
Aldeyra Therapeutics (ALDX) US $0.333B 0.00
Cybin (HELP) CA $0.298B 0.00
Relmada Therapeutics (RLMD) US $0.285B 0.00
Larimar Therapeutics (LRMR) US $0.279B 0.00
Journey Medical (DERM) US $0.278B 0.00
Enlivex Therapeutics (ENLV) IL $0.275B 0.00
Avalo Therapeutics (AVTX) US $0.263B 0.00
OmniAb (OABI) US $0.245B 0.00
Profound Medical (PROF) CA $0.236B 0.00
Heron Therapeutics (HRTX) US $0.231B 0.00
MediWound (MDWD) IL $0.228B 0.00
Achieve Life Sciences (ACHV) CA $0.226B 0.00
Silence Therapeutics (SLN) GB $0.224B 0.00
Context Therapeutics (CNTX) US $0.209B 0.00
Minerva Neurosciences (NERV) US $0.208B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.199B 0.00
Surrozen (SRZN) US $0.195B 0.00
Innate Pharma SA (IPHYF) FR $0.181B 0.00
Galectin Therapeutics (GALT) US $0.181B 0.00
AleAnna (ANNA) US $0.179B 0.00
Century Therapeutics (IPSC) US $0.149B 0.00
VAXART, INC (VXRT) US $0.146B 0.00
Unicycive Therapeutics (UNCY) US $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.137B 0.00
Prelude Therapeutics (PRLD) US $0.136B 0.00
Inhibikase Therapeutics (IKT) US $0.128B 0.00
Avita Medical (RCEL) US $0.119B 0.00
Korro Bio (KRRO) US $0.118B 0.00
Karyopharm Therapeutics (KPTI) US $0.115B 0.00
Cardiol Therapeutics (CRDL) CA $0.111B 0.00
Verrica Pharmaceuticals (VRCA) US $0.110B 0.00
Incannex Healthcare (IXHL) AU $0.100B 0.00
Vivani Medical (VANI) US $0.098B 0.00
Cassava Sciences (SAVA) US $0.098B 0.00
Pyxis Oncology (PYXS) US $0.094B 0.00
Champions Oncology (CSBR) US $0.091B 38.53
Assertio Holdings (ASRT) US $0.082B 0.00
PolyPid (PYPD) IL $0.072B 0.00
HST Global (HSTC) US $0.069B 0.00
Gain Therapeutics (GANX) US $0.067B 0.00
Rafael Holdings (RFL) US $0.063B 0.00
Dominari Holdings (DOMH) US $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.058B 48.88
Procaps Group, S.A (PROCF) LU $0.058B 0.00
Fractyl Health (GUTS) US $0.057B 0.00
NRx Pharmaceuticals (NRXP) US $0.057B 0.00
BioNxt Solutions (BNXTF) CA $0.056B 0.00
PMV Pharmaceuticals (PMVP) US $0.055B 0.00
Nutriband (NTRB) US $0.053B 0.00
Acrivon Therapeutics (ACRV) US $0.053B 0.00
Liminatus Pharma (LIMN) US $0.050B 0.00
Lipocine (LPCN) US $0.047B 0.00
ElectroCore (ECOR) US $0.044B 0.00
Telomir Pharmaceuticals (TELO) US $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) US $0.039B 0.00
Talphera (TLPH) US $0.038B 0.00
Plus Therapeutics (PSTV) US $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.033B 0.00
SCYNEXIS (SCYX) US $0.032B 0.00
Wellgistics Health (WGRX) US $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.028B 0.00
TherapeuticsMD (TXMD) US $0.027B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
Natural Alternatives (NAII) US $0.020B 0.00
Scienture Holdings (SCNX) US $0.019B 0.00
VYNE Therapeutics (VYNE) US $0.019B 0.00
Klotho Neurosciences (KLTO) US $0.018B 0.00
Cosmos Health (COSM) US $0.017B 0.00
Iterum Therapeutics (ITRM) IE $0.016B 0.00
Citius Pharmaceuticals (CTXR) US $0.016B 0.00
Traws Pharma (TRAW) US $0.016B 0.02
Vyome Holdings (HIND) US $0.015B 0.00
Vivos Therapeutics (VVOS) US $0.015B 0.00
Inotiv (NOTV) US $0.014B 0.00
Mannatech (MTEX) US $0.014B 0.00
BioLineRx (BLRX) IL $0.013B 0.00
Tempest Therapeutics (TPST) US $0.012B 0.00
CASI Pharmaceuticals (CASI) CN $0.011B 0.00
Phio Pharmaceuticals (PHIO) US $0.010B 0.00
Addex Therapeutics (ADXN) CH $0.010B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.009B 0.00
Ainos (AIMD) US $0.009B 0.00
BioVie (BIVI) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
Kiora Pharmaceuticals (KPRX) US $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Biomerica (BMRA) US $0.007B 0.00
Mangoceuticals (MGRX) US $0.006B 0.00
Alaunos Therapeutics (TCRT) US $0.006B 0.00
Quoin Pharmaceuticals (QNRX) US $0.006B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
Heatwurx (PCSA) US $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
Indaptus Therapeutics (INDP) US $0.004B 0.00
Lyra Therapeutics (LYRA) US $0.003B 0.00
Ernexa Therapeutics (ERNA) US $0.003B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.003B 0.00
XORTX Therapeutics (XRTX) CA $0.003B 0.00
InMed Pharmaceuticals (INM) CA $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.003B 0.00
Jaguar Animal Health (JAGX) US $0.003B 0.00
SciSparc (SPRC) IL $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
Clearmind Medicine (CMND) CA $0.002B 0.00
CDT Equity (CDT) US $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.001B 0.00
Aditxt (ADTX) US $0.000B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
Grifols, S.A (GRFS) ES $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
PainReform (PRFX) IL $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00